Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

High-pressure headaches: idiopathic intracranial hypertension and its mimics

Abstract

Idiopathic intracranial hypertension (IIH) is a rare disorder that typically affects obese women of childbearing age, but can also occur in paediatric populations. Patients usually present with diffuse, daily headache and visual disturbances, but either symptom can occur in isolation. Patients with IIH often have papilloedema; however, IIH without papilloedema is fairly common in patients with chronic daily headache. The pathogenesis of IIH is unknown; the high incidence of comorbid bilateral transverse sinus stenosis (BTSS) in patients with IIH suggests that the two conditions are linked, although no direct causal relationship has been established. Cerebrospinal fluid (CSF) pressure monitoring or lumbar puncture—which provides immediate symptomatic relief—are important in making a diagnosis of IIH. Current treatments for IIH include weight reduction, medical treatment, CSF diversion surgery, optic nerve sheath fenestration and, potentially, endovascular stenting (in patients with BTSS). Prevention of visual loss (which can be substantial) is the main goal of treatment. Residual headache and IIH recurrence are not uncommon after treatment, and regular follow-up is, therefore, warranted even in patients who achieve remission. This Review provides an update of current knowledge of the aetiology, pathophysiology and treatment of IIH.

Key Points

  • Idiopathic intracranial hypertension (IIH) is a rare headache disorder that predominantly affects obese women of childbearing age

  • Diagnosis of IIH requires exclusion of metabolic, endocrine and drug-related aetiologies; magnetic resonance venography is crucial to identify venous thrombosis and bilateral transverse sinus stenosis

  • The most common symptoms of IIH are headache, papilloedema and pulsatile tinnitus; however, patients might not present with all three symptoms

  • In patients with suspected IIH, symptomatic relief resulting from a decrease in CSF pressure (achieved by lumbar puncture) confirms the diagnosis

  • Current treatment options for IIH include lumbar puncture, diversion surgery, optic nerve sheath fenestration, and weight reduction (in obese individuals)

  • Visual loss is likely in patients with IIH who are male, of African ancestry, or have systemic hypertension, anaemia or obesity—close follow-up is recommended for these patient populations

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Magnetic resonance cerebral venography findings in a 32-year-old woman with idiopathic intracranial hypertension.
Figure 2: A possible link between cerebral venous stenosis and increased ICP.

Similar content being viewed by others

References

  1. Durcan, F. J., Corbett, J. J. & Wall, M. The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch. Neurol. 45, 875–877 (1988).

    Article  CAS  PubMed  Google Scholar 

  2. Gjerris, F., Soelberg Sorensen, P., Vorstrup, S. & Paulson, O. B. Intracranial pressure, conductance to cerebrospinal fluid outflow, and cerebral blood flow in patients with benign intracranial hypertension (pseudotumor cerebri). Ann. Neurol. 17, 158–162 (1985).

    Article  CAS  PubMed  Google Scholar 

  3. Soelberg Sorensen, P., Gjerris, F. & Svenstrup, B. Endocrine studies in patients with pseudotumor cerebri. Estrogen levels in blood and cerebrospinal fluid. Arch. Neurol. 43, 902–906 (1986).

    Article  CAS  PubMed  Google Scholar 

  4. King, J. O., Mitchell, P. J., Thomson, K. R. & Tress, B. M. Cerebral venography and manometry in idiopathic intracranial hypertension. Neurology 45, 2224–2228 (1995).

    Article  CAS  PubMed  Google Scholar 

  5. Karahalios, D. G., Rekate, H. L., Khayata, M. H. & Apostolides, P. J. Elevated intracranial venous pressure as a universal mechanism in pseudotumor cerebri of varying etiologies. Neurology 46, 198–202 (1996).

    Article  CAS  PubMed  Google Scholar 

  6. Bono, F. et al. Bilateral transverse sinus stenosis predicts IIH without papilledema in patients with migraine. Neurology 67, 419–423 (2006).

    Article  CAS  PubMed  Google Scholar 

  7. Bono, F. et al. Bilateral transverse sinus stenosis and idiopathic intracranial hypertension without papilledema in chronic tension-type headache. J. Neurol. 255, 807–812 (2008).

    Article  CAS  PubMed  Google Scholar 

  8. Radhakrishnan, K., Thacker, A. K., Bohlaga, N. H., Maloo, J. C. & Gerryo, S. E. Epidemiology of idiopathic intracranial hypertension: a prospective and case–control study. J. Neurol. Sci. 116, 18–28 (1993).

    Article  CAS  PubMed  Google Scholar 

  9. Digre, K. B. et al. A comparison of idiopathic intracranial hypertension with and without papilledema. Headache 49, 185–193 (2009).

    Article  PubMed  PubMed Central  Google Scholar 

  10. Rowe, F. J. Assessment of visual function in idiopathic intracranial hypertension. Br. J. Neurosurg. 25, 45–54 (2011).

    Article  PubMed  Google Scholar 

  11. Dandy, W. Intracranial pressure without brain tumor: diagnosis and treatment. Ann. Surg. 106, 492–513 (1937).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Smith, J. L. Whence pseudotumor cerebri? J. Clin. Neuroophthalmol. 5, 55–56 (1985).

    CAS  PubMed  Google Scholar 

  13. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 24 (Suppl. 1), 9–160 (2004).

  14. Yabe, I., Moriwaka, F., Notoya, A., Ohtaki, M. & Tashiro, K. Incidence of idiopathic intracranial hypertension in Hokkaido, the northernmost island of Japan. J. Neurol. 247, 474–475 (2000).

    Article  CAS  PubMed  Google Scholar 

  15. Friesner, D., Rosenman, R., Lobb, B. M. & Tanne, E. Idiopathic intracranial hypertension in the USA: the role of obesity in establishing prevalence and healthcare costs. Obes. Rev. 12, e372–e380 (2011).

    Article  CAS  PubMed  Google Scholar 

  16. Raoof, N., Sharrack, B., Pepper, I. M. & Hickman, S. J. The incidence and prevalence of idiopathic intracranial hypertension in Sheffield, UK. Eur. J. Neurol. 18, 1266–1268 (2011).

    Article  CAS  PubMed  Google Scholar 

  17. Galvin, J. A. & Van Stavern, G. P. Clinical characterization of idiopathic intracranial hypertension at the Detroit Medical Center. J. Neurol. Sci. 223, 157–160 (2004).

    Article  PubMed  Google Scholar 

  18. Mezaal, M. & Saadah, M. Idiopathic intracranial hypertension in Dubai: nature and prognosis. Acta Neurol. Scand. 112, 298–302 (2005).

    Article  CAS  PubMed  Google Scholar 

  19. Radhakrishnan, K., Ahlskog, J. E., Cross, S. A., Kurland, L. T. & O'Fallon, W. M. Idiopathic intracranial hypertension (pseudotumor cerebri). Descriptive epidemiology in Rochester, Minn, 1976 to 1990. Arch. Neurol. 50, 78–80 (1993).

    Article  CAS  PubMed  Google Scholar 

  20. Kim, T. W., Choung, H. K., Khwarg, S. I., Hwang, J.-M. & Yang, H. J. Obesity may not be a risk factor for idiopathic intracranial hypertension in Asians. Eur. J. Neurol. 15, 876–879 (2008).

    Article  PubMed  Google Scholar 

  21. Liu, I.-H., Wang, A.-G. & Yen, M.-Y. Idiopathic intracranial hypertension: clinical features in Chinese patients. Jpn J. Ophthalmol. 55, 138–142 (2011).

    Article  PubMed  Google Scholar 

  22. Bruce, B. B., Preechawat, P., Newman, N. J., Lynn, M. J. & Biousse, V. Racial differences in idiopathic intracranial hypertension. Neurology 70, 861–867 (2008).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Glueck, C. J. et al. Idiopathic intracranial hypertension, polycystic-ovary syndrome, and thrombophilia. J. Lab. Clin. Med. 145, 72–82 (2005).

    Article  PubMed  Google Scholar 

  24. Kesler, A., Hadayer, A., Goldhammer, Y., Almog, Y. & Korczyn, A. D. Idiopathic intracranial hypertension: risk of recurrences. Neurology 63, 1737–1739 (2004).

    Article  CAS  PubMed  Google Scholar 

  25. Szewka, A. J., Bruce, B. B., Newman, N. J. & Biousse, V. Idiopathic intracranial hypertension: relation between obesity and visual outcomes. J. Neuroophthalmol. http://dx.doi.org/10.1097/WNO.0b013e31823f852d.

  26. Bruce, B. B. et al. Atypical idiopathic intracranial hypertension: normal BMI and older patients. Neurology 74, 1827–1832 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Bruce, B. B. et al. Idiopathic intracranial hypertension in men. Neurology 72, 304–309 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Lee, A. G. et al. Sleep apnea and intracranial hypertension in men. Ophthalmology 109, 482–485 (2002).

    Article  PubMed  Google Scholar 

  29. Hung., H. L., Kao, L. Y. & Huang, C. C. Ophthalmic features of idiopathic intracranial hypertension. Eye (Lond.) 17, 793–795 (2003).

    Article  Google Scholar 

  30. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363, 157–163 (2004).

  31. Zheng, W. et al. Association between body-mass index and risk of death in more than 1 million Asians. N. Engl. J. Med. 364, 719–729 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Babikian, P., Corbett, J. & Bell, W. Idiopathic intracranial hypertension in children: the Iowa experience. J. Child. Neurol. 9, 144–149 (1994).

    Article  CAS  PubMed  Google Scholar 

  33. Kesler, A. & Fattal-Valevski, A. Idiopathic intracranial hypertension in the pediatric population. J. Child. Neurol. 17, 745–748 (2002).

    Article  PubMed  Google Scholar 

  34. Ng, Y. T. & Bodensteiner, J. B. Idiopathic intracranial hypertension in the pediatric population. J. Child. Neurol. 18, 440 (2003).

    Article  PubMed  Google Scholar 

  35. Cinciripini, G. S., Donahue, S. & Borchert, M. S. Idiopathic intracranial hypertension in prepubertal pediatric patients: characteristics, treatment, and outcome. Am. J. Ophthalmol. 127, 178–182 (1999).

    Article  CAS  PubMed  Google Scholar 

  36. Weisberg, L. A. & Chutorian, A. M. Pseudotumor cerebri of childhood. Am. J. Dis. Child. 131, 1243–1248 (1977).

    CAS  PubMed  Google Scholar 

  37. Balcer, L. J. et al. Idiopathic intracranial hypertension: relation of age and obesity in children. Neurology 52, 870–872 (1999).

    Article  CAS  PubMed  Google Scholar 

  38. Brara, S. M., Koebnick, C., Porter, A. H. & Langer-Gould, A. Pediatric idiopathic intracranial hypertension and extreme childhood obesity. J. Pediatr. 161, 602–607 (2012).

    Article  PubMed  PubMed Central  Google Scholar 

  39. Faz, G., Butler, I. J. & Koenig, M. K. Incidence of papilledema and obesity in children diagnosed with idiopathic “benign” intracranial hypertension: case series and review. J. Child. Neurol. 25, 1389–1392 (2010).

    Article  PubMed  PubMed Central  Google Scholar 

  40. Wall, M. & George, D. Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain 114, 155–180 (1991).

    Article  PubMed  Google Scholar 

  41. Marcelis, J. & Silberstein, S. D. Idiopathic intracranial hypertension without papilledema. Arch. Neurol. 48, 392–399 (1991).

    Article  CAS  PubMed  Google Scholar 

  42. Lim, M., Kurian, M., Penn, A., Calver, D. & Lin, J. P. Visual failure without headache in idiopathic intracranial hypertension. Arch. Dis. Child. 90, 206–210 (2005).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Corbett, J. J. et al. Visual loss in pseudotumor cerebri. Follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss. Arch. Neurol. 39, 461–474 (1982).

    Article  CAS  PubMed  Google Scholar 

  44. Hayreh, S. S. Optic disc edema in raised intracranial pressure. VI. Associated visual disturbances and their pathogenesis. Arch. Ophthalmol. 95, 1566–1579 (1977).

    Article  CAS  PubMed  Google Scholar 

  45. Rowe, F. J. & Sarkies, N. J. Assessment of visual function in idiopathic intracranial hypertension: a prospective study. Eye (Lond.) 12, 111–118 (1998).

    Article  Google Scholar 

  46. Rowe, F. J. & Sarkies, N. J. Visual outcome in a prospective study of idiopathic intracranial hypertension. Arch. Ophthalmol. 117, 1571 (1999).

    Article  CAS  PubMed  Google Scholar 

  47. Bruce, B. B., Newman, N. J. & Biousse, V. Ophthalmoparesis in idiopathic intracranial hypertension. Am. J. Ophthalmol. 142, 878–880 (2006).

    Article  PubMed  Google Scholar 

  48. Lipton, H. L. & Michelson, P. E. Pseudotumor cerebri syndrome without papilledema. JAMA 220, 1591–1592 (1972).

    Article  CAS  PubMed  Google Scholar 

  49. Wang, S. J., Silberstein, S. D., Patterson, S. & Young, W. B. Idiopathic intracranial hypertension without papilledema: a case-control study in a headache center. Neurology 51, 245–249 (1998).

    Article  CAS  PubMed  Google Scholar 

  50. Torbey, M. T., Geocadin, R. G., Razumovsky, A. Y., Rigamonti, D. & Williams, M. A. Utility of CSF pressure monitoring to identify idiopathic intracranial hypertension without papilledema in patients with chronic daily headache. Cephalalgia 24, 495–502 (2004).

    Article  CAS  PubMed  Google Scholar 

  51. Donnet, A. et al. Endovascular treatment of idiopathic intracranial hypertension: clinical and radiologic outcome of 10 consecutive patients. Neurology 70, 641–647 (2008).

    Article  CAS  PubMed  Google Scholar 

  52. Ahmed, R. M. et al. Transverse sinus stenting for idiopathic intracranial hypertension: a review of 52 Patients and of model predictions. AJNR Am. J. Neuroradiol. (2011).

  53. Friedman, D. I. & Jacobson, D. M. Diagnostic criteria for idiopathic intracranial hypertension. Neurology 59, 1492–1495 (2002).

    Article  PubMed  Google Scholar 

  54. Silver, R. I., Moonis, G., Schlosser, R. J., Bolger, W. E. & Loevner, L. A. Radiographic signs of elevated intracranial pressure in idiopathic cerebrospinal fluid leaks: a possible presentation of idiopathic intracranial hypertension. Am. J. Rhinol. 21, 257–261 (2007).

    Article  PubMed  Google Scholar 

  55. Bradley, W. G., Daroff, R. B., Fenichel, G. M. & Jankovic J. (Eds). Neurology in Clinical Practice 5th edn (Butterworth-Heinemann, Oxford, 2007).

    Google Scholar 

  56. Gilland, O., Tourtellotte, W. W., O'Tauma, L. & Henderson, W. G. Normal cerebrospinal fluid pressure. J. Neurosurg. 40, 587–593 (1974).

    Article  CAS  PubMed  Google Scholar 

  57. Whiteley, W., Al-Shahi, R., Warlow, C. P., Zeidler, M. & Lueck, C. J. CSF opening pressure: reference interval and the effect of body mass index. Neurology 67, 1690–1691 (2006).

    Article  CAS  PubMed  Google Scholar 

  58. Avery, R. A. et al. Reference range for cerebrospinal fluid opening pressure in children. N. Engl. J. Med. 363, 891–893 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Bono, F. et al. Obesity does not induce abnormal CSF pressure in subjects with normal cerebral MR venography. Neurology 59, 1641–1643 (2002).

    Article  CAS  PubMed  Google Scholar 

  60. Bono, F. et al. Abnormal pressure waves in headache sufferers with bilateral transverse sinus stenosis. Cephalalgia 30, 1419–1425 (2010).

    Article  CAS  PubMed  Google Scholar 

  61. Czosnyka, M. & Pickard, J. D. Monitoring and interpretation of intracranial pressure. J. Neurol. Neurosurg. Psychiatry 75, 813–821 (2004).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Agid, R., Farb, R. I., Willinsky, R. A., Mikulis, D. J. & Tomlinson, G. Idiopathic intracranial hypertension: the validity of cross-sectional neuroimaging signs. Neuroradiology 48, 521–527 (2006).

    Article  CAS  PubMed  Google Scholar 

  63. Brodsky, M. C. & Vaphiades, M. Magnetic resonance imaging in pseudotumor cerebri. Ophthalmology 105, 1686–1693 (1998).

    Article  CAS  PubMed  Google Scholar 

  64. Connolly, M. B., Farrell, K., Hill, A. & Flodmark, O. Magnetic resonance imaging in pseudotumor cerebri. Dev. Med. Child. Neurol. 34, 1091–1094 (1992).

    Article  CAS  PubMed  Google Scholar 

  65. Gass, A. et al. MRI of the optic nerve in benign intracranial hypertension. Neuroradiology 38, 769–773 (1996).

    Article  CAS  PubMed  Google Scholar 

  66. Jinkins, J. R. et al. MR of optic papilla protrusion in patients with high intracranial pressure. AJNR Am. J. Neuroradiol. 17, 665–668 (1996).

    CAS  PubMed  Google Scholar 

  67. Manfre, L. et al. Idiopathic intracranial hypertension: orbital MRI. Neuroradiology 37, 459–461 (1995).

    Article  CAS  PubMed  Google Scholar 

  68. Silbergleit, R., Junck, L., Gebarski, S. S. & Hatfield, M. K. Idiopathic intracranial hypertension (pseudotumor cerebri): MR imaging. Radiology 170, 207–209 (1989).

    Article  CAS  PubMed  Google Scholar 

  69. Yuh, W. T. et al. MR imaging of pituitary morphology in idiopathic intracranial hypertension. J. Magn. Reson. Imaging 12, 808–813 (2000).

    Article  CAS  PubMed  Google Scholar 

  70. Maralani, P. J. et al. Accuracy of brain imaging in the diagnosis of idiopathic intracranial hypertension. Clin. Radiol. 67, 656–663 (2012).

    Article  CAS  PubMed  Google Scholar 

  71. Geeraerts, T. et al. Use of T2-weighted magnetic resonance imaging of the optic nerve sheath to detect raised intracranial pressure. Crit. Care 12, R114 (2008).

    Article  PubMed  PubMed Central  Google Scholar 

  72. Leach, J. L., Fortuna, R. B., Jones, B. V. & Gaskill-Shipley, M. F. Imaging of cerebral venous thrombosis: current techniques, spectrum of findings, and diagnostic pitfalls. Radiographics 26 (Suppl. 1), S19–S41 (2006).

    Article  PubMed  Google Scholar 

  73. Farb, R. I. et al. Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology 60, 1418–1424 (2003).

    Article  CAS  PubMed  Google Scholar 

  74. Zada, G., Tirosh, A., Kaiser, U. B., Laws, E. R. & Woodmansee, W. W. Cushing's disease and idiopathic intracranial hypertension: case report and review of underlying pathophysiological mechanisms. J. Clin. Endocrinol. Metab. 95, 4850–4854 (2010).

    Article  CAS  PubMed  Google Scholar 

  75. Mowl, A. D., Grogg, J. A. & Klein, J. Secondary pseudotumour cerebri in a patient undergoing sexual reassignment therapy. Clin. Exp. Optom. 92, 449–453 (2009).

    Article  PubMed  Google Scholar 

  76. Fraser, J. A. et al. Risk factors for idiopathic intracranial hypertension in men: a case–control study. J. Neurol. Sci. 290, 86–89 (2010).

    Article  PubMed  Google Scholar 

  77. Condulis, N., Germain, G., Charest, N., Levy, S. & Carpenter, T. O. Pseudotumor cerebri: a presenting manifestation of Addison's disease. Clin. Pediatr. (Phila.) 36, 711–713 (1997).

    Article  CAS  Google Scholar 

  78. Walker, A. E. & Adamkiewicz, J. J. Pseudotumor cerebri associated with prolonged corticosteroid therapy. Reports of four cases. JAMA 188, 779–784 (1964).

    CAS  PubMed  Google Scholar 

  79. Martin, N. A., Linfoot, J. & Wilson, C. B. Development of pseudotumor cerebri after the removal of an adrenocorticotropic hormone-secreting pituitary adenoma: case report. Neurosurgery 8, 699–702 (1981).

    Article  CAS  PubMed  Google Scholar 

  80. Amaral, J. F., Tsiaris, W., Morgan, T. & Thompson, W. R. Reversal of benign intracranial hypertension by surgically induced weight loss. Arch. Surg. 122, 946–949 (1987).

    Article  CAS  PubMed  Google Scholar 

  81. Sinclair, A. J. et al. Exploring the pathogenesis of IIH: an inflammatory perspective. J. Neuroimmunol. 201–202, 212–220 (2008).

    Article  CAS  PubMed  Google Scholar 

  82. Sinclair, A. J. et al. Cerebrospinal fluid corticosteroid levels and cortisol metabolism in patients with idiopathic intracranial hypertension: a link between 11β-HSD1 and intracranial pressure regulation? J. Clin. Endocrinol. Metab. 95, 5348–5356 (2010).

    Article  CAS  PubMed  Google Scholar 

  83. Giuseffi, V., Wall, M., Siegel, P. Z. & Rojas, P. B. Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): a case–control study. Neurology 41, 239–244 (1991).

    Article  CAS  PubMed  Google Scholar 

  84. Sheldon, R. S., Becker, W. J., Hanley, D. A. & Culver, R. L. Hypoparathyroidism and pseudotumor cerebri: an infrequent clinical association. Can. J. Neurol. Sci. 14, 622–625 (1987).

    CAS  PubMed  Google Scholar 

  85. Chiu, A. M. et al. Minocycline treatment and pseudotumor cerebri syndrome. Am. J. Ophthalmol. 126, 116–121 (1998).

    Article  CAS  PubMed  Google Scholar 

  86. Kesler, A., Goldhammer, Y., Hadayer, A. & Pianka, P. The outcome of pseudotumor cerebri induced by tetracycline therapy. Acta Neurol. Scand. 110, 408–411 (2004).

    Article  CAS  PubMed  Google Scholar 

  87. Lochhead, J. & Elston, J. S. Doxycycline induced intracranial hypertension. BMJ 326, 641–642 (2003).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  88. Kasarskis, E. J. & Bass, N. H. Benign intracranial hypertension induced by deficiency of vitamin A during infancy. Neurology 32, 1292–1295 (1982).

    Article  CAS  PubMed  Google Scholar 

  89. Jacobson, D. M. et al. Serum vitamin A concentration is elevated in idiopathic intracranial hypertension. Neurology 53, 1114–1118 (1999).

    Article  CAS  PubMed  Google Scholar 

  90. Fishman, R. A. Polar bear liver, vitamin A, aquaporins, and pseudotumor cerebri. Ann. Neurol. 52, 531–533 (2002).

    Article  PubMed  Google Scholar 

  91. Lueck, C. & McIlwaine, G. Interventions for idiopathic intracranial hypertension. Cochrane Database of Systematic Reviews, Issue 1. Art. No.: CD003434. http://dx.doi.org/10.1002/14651858.CD003434.pub2.

  92. Newborg, B. Pseudotumor cerebri treated by rice reduction diet. Arch. Intern. Med. 133, 802–807 (1974).

    Article  CAS  PubMed  Google Scholar 

  93. Kupersmith, M. J. et al. Effects of weight loss on the course of idiopathic intracranial hypertension in women. Neurology 50, 1094–1098 (1998).

    Article  CAS  PubMed  Google Scholar 

  94. Johnson, L. N., Krohel, G. B., Madsen, R. W. & March, G. A. Jr. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology 105, 2313–2317 (1998).

    Article  CAS  PubMed  Google Scholar 

  95. Sinclair, A. J. et al. Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. BMJ 341, c2701 (2010).

    Article  PubMed  PubMed Central  Google Scholar 

  96. Sugerman, H. J. et al. Gastric surgery for pseudotumor cerebri associated with severe obesity. Ann. Surg. 229, 634–640 (1999).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. Nadkarni, T., Rekate, H. L. & Wallace, D. Resolution of pseudotumor cerebri after bariatric surgery for related obesity. Case report. J. Neurosurg. 101, 878–880 (2004).

    Article  PubMed  Google Scholar 

  98. Carrion, E., Hertzog, J. H., Medlock, M. D., Hauser, G. J. & Dalton, H. J. Use of acetazolamide to decrease cerebrospinal fluid production in chronically ventilated patients with ventriculopleural shunts. Arch. Dis. Child. 84, 68–71 (2001).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  99. Rubin, R. C., Henderson, E. S., Ommaya, A. K., Walker, M. D. & Rall, D. P. The production of cerebrospinal fluid in man and its modification by acetazolamide. J. Neurosurg. 25, 430–436 (1966).

    Article  CAS  PubMed  Google Scholar 

  100. McCarthy, K. D. & Reed, D. J. The effect of acetazolamide and furosemide on cerebrospinal fluid production and choroid plexus carbonic anhydrase activity. J. Pharmacol. Exp. Ther. 189, 194–201 (1974).

    CAS  PubMed  Google Scholar 

  101. Ball, A. K. et al. A randomised controlled trial of treatment for idiopathic intracranial hypertension. J. Neurol. 258, 874–881 (2011).

    Article  CAS  PubMed  Google Scholar 

  102. NORDIC Clinical Trials. Nordicclinicaltrials.com [online]

  103. Liu, G. T., Glaser, J. S. & Schatz, N. J. High-dose methylprednisolone and acetazolamide for visual loss in pseudotumor cerebri. Am. J. Ophthalmol. 118, 88–96 (1994).

    Article  CAS  PubMed  Google Scholar 

  104. Soler, D., Cox, T., Bullock, P., Calver, D. M. & Robinson, R. O. Diagnosis and management of benign intracranial hypertension. Arch. Dis. Child. 78, 89–94 (1998).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  105. Sorensen, P. S., Krogsaa, B. & Gjerris, F. Clinical course and prognosis of pseudotumor cerebri. A prospective study of 24 patients. Acta Neurol. Scand. 77, 164–172 (1988).

    Article  CAS  PubMed  Google Scholar 

  106. Ko, M. W. et al. Weight gain and recurrence in idiopathic intracranial hypertension: a case–control study. Neurology 76, 1564–1567 (2011).

    Article  CAS  PubMed  Google Scholar 

  107. Thambisetty, M., Lavin, P. J., Newman, N. J. & Biousse, V. Fulminant idiopathic intracranial hypertension. Neurology 68, 229–232 (2007).

    Article  PubMed  Google Scholar 

  108. Celebisoy, N., Gokcay, F., Sirin, H. & Akyurekli, O. Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol. Scand. 116, 322–327 (2007).

    Article  CAS  PubMed  Google Scholar 

  109. Panagopoulos, G. N. et al. Octreotide: a therapeutic option for idiopathic intracranial hypertension. Neurol. Neurophysiol. Neurosci. 10, 1 (2007).

    Google Scholar 

  110. Forderreuther, S. & Straube, A. Indomethacin reduces CSF pressure in intracranial hypertension. Neurology 55, 1043–1045 (2000).

    Article  CAS  PubMed  Google Scholar 

  111. London, E. & Castonguay, T. W. Diet and the role of 11β-hydroxysteroid dehydrogenase-1 on obesity. J. Nutr. Biochem. 20, 485–493 (2009).

    Article  CAS  PubMed  Google Scholar 

  112. Hermanowski-Vosatka, A. et al. 11β-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice. J. Exp. Med. 202, 517–527 (2005).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  113. Johnston, I. & Paterson, A. Benign intracranial hypertension. II. CSF pressure and circulation. Brain 97, 301–312 (1974).

    Article  CAS  PubMed  Google Scholar 

  114. Bateman, G. A., Stevens, S. A. & Stimpson, J. A mathematical model of idiopathic intracranial hypertension incorporating increased arterial inflow and variable venous outflow collapsibility. J. Neurosurg. 110, 446–456 (2009).

    Article  PubMed  Google Scholar 

  115. Rosenberg, M. L. et al. Cerebrospinal fluid diversion procedures in pseudotumor cerebri. Neurology 43, 1071–1072 (1993).

    Article  CAS  PubMed  Google Scholar 

  116. Sinclair, A. J. et al. Is cerebrospinal fluid shunting in idiopathic intracranial hypertension worthwhile? A 10-year review. Cephalalgia 31, 1627–1633 (2011).

    Article  PubMed  Google Scholar 

  117. Abubaker, K. et al. Idiopathic intracranial hypertension: lumboperitoneal shunts versus ventriculoperitoneal shunts—case series and literature review. Br. J. Neurosurg. 25, 94–99 (2011).

    Article  PubMed  Google Scholar 

  118. McGirt, M. J. et al. Cerebrospinal fluid shunt placement for pseudotumor cerebri-associated intractable headache: predictors of treatment response and an analysis of long-term outcomes. J. Neurosurg. 101, 627–632 (2004).

    Article  PubMed  Google Scholar 

  119. De Wecker, L. On incision of the optic nerve in cases of neuroretinitis. Int. Ophthalmol. Cong. Reps 4, 11–14 (1872).

    Google Scholar 

  120. Kelman, S. E., Heaps, R., Wolf, A. & Elman, M. J. Optic nerve decompression surgery improves visual function in patients with pseudotumor cerebri. Neurosurgery 30, 391–395 (1992).

    Article  CAS  PubMed  Google Scholar 

  121. Sergott, R. C., Savino, P. J. & Bosley, T. M. Modified optic nerve sheath decompression provides long-term visual improvement for pseudotumor cerebri. Arch. Ophthalmol. 106, 1384–1390 (1988).

    Article  CAS  PubMed  Google Scholar 

  122. Corbett, J. J., Nerad, J. A., Tse, D. T. & Anderson, R. L. Results of optic nerve sheath fenestration for pseudotumor cerebri. The lateral orbitotomy approach. Arch. Ophthalmol. 106, 1391–1397 (1988).

    Article  CAS  PubMed  Google Scholar 

  123. Goh, K. Y., Schatz, N. J. & Glaser, J. S. Optic nerve sheath fenestration for pseudotumor cerebri. J. Neuroophthalmol. 17, 86–91 (1997).

    Article  CAS  PubMed  Google Scholar 

  124. Spoor, T. C. & McHenry, J. G. Long-term effectiveness of optic nerve sheath decompression for pseudotumor cerebri. Arch. Ophthalmol. 111, 632–635 (1993).

    Article  CAS  PubMed  Google Scholar 

  125. Plotnik, J. L. & Kosmorsky, G. S. Operative complications of optic nerve sheath decompression. Ophthalmology 100, 683–690 (1993).

    Article  CAS  PubMed  Google Scholar 

  126. Mauriello, J. A. Jr, Shaderowfsky, P., Gizzi, M. & Frohman, L. Management of visual loss after optic nerve sheath decompression in patients with pseudotumor cerebri. Ophthalmology 102, 441–445 (1995).

    Article  PubMed  Google Scholar 

  127. Banta, J. T. & Farris, B. K. Pseudotumor cerebri and optic nerve sheath decompression. Ophthalmology 107, 1907–1912 (2000).

    Article  CAS  PubMed  Google Scholar 

  128. Higgins, J. N., Owler, B. K., Cousins, C. & Pickard, J. D. Venous sinus stenting for refractory benign intracranial hypertension. Lancet 359, 228–230 (2002).

    Article  PubMed  Google Scholar 

  129. Higgins, J. N. P., Cousins, C., Owler, B. K., Sarkies, N. & Pickard, J. D. Idiopathic intracranial hypertension: 12 cases treated by venous sinus stenting. J. Neurol. Neurosurg. Psychiatr. 74, 1662–1666 (2003).

    Article  CAS  Google Scholar 

  130. Higgins, J. N., Cousins, C., Owler, B. K., Sarkies, N. & Pickard, J. D. Idiopathic intracranial hypertension: 12 cases treated by venous sinus stenting. J. Neurol. Neurosurg. Psychiatry 74, 1662–1666 (2003).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  131. Ahmed, R., Friedman, D. I. & Halmagyi, G. M. Stenting of the transverse sinuses in idiopathic intracranial hypertension. J. Neuroophthalmol. 31, 374–380 (2011).

    Article  PubMed  Google Scholar 

  132. Albuquerque, F. C. et al. Intracranial venous sinus stenting for benign intracranial hypertension: clinical indications, technique, and preliminary results. World Neurosurg. 75, 648–652 (2011).

    Article  PubMed  Google Scholar 

  133. Bussière, M. et al. Unilateral transverse sinus stenting of patients with idiopathic intracranial hypertension. AJNR Am. J. Neuroradiol. 31, 645–650 (2010).

    Article  PubMed  Google Scholar 

  134. Fields, J. D. et al. Dural venous sinus angioplasty and stenting for the treatment of idiopathic intracranial hypertension. J. Neurointerv Surg. http://dx.doi.org/10.1136/neurintsurg-2011-010156.

  135. Shah, V. A., Kardon, R. H., Lee, A. G., Corbett, J. J. & Wall, M. Long-term follow-up of idiopathic intracranial hypertension: the Iowa experience. Neurology 70, 634–640 (2008).

    Article  CAS  PubMed  Google Scholar 

  136. Mathew, N. T., Ravishankar, K. & Sanin, L. C. Coexistence of migraine and idiopathic intracranial hypertension without papilledema. Neurology 46, 1226–1230 (1996).

    Article  CAS  PubMed  Google Scholar 

  137. Mathews, M. K., Sergott, R. C. & Savino, P. J. Pseudotumor cerebri. Curr. Opin. Ophthalmol. 14, 364–370 (2003).

    Article  PubMed  Google Scholar 

  138. Phillips, P. H., Repka, M. X. & Lambert, S. R. Pseudotumor cerebri in children. J. AAPOS 2, 33–38 (1998).

    Article  CAS  PubMed  Google Scholar 

  139. Tibussek, D. et al. Clinical spectrum of the pseudotumor cerebri complex in children. Childs Nerv. Syst. 26, 313–321 (2010).

    Article  PubMed  Google Scholar 

  140. Soiberman, U. et al. Idiopathic intracranial hypertension in children: visual outcome and risk of recurrence. Childs Nerv. Syst. 27, 1913–1918 (2011).

    Article  PubMed  Google Scholar 

  141. Boulton, M. et al. Raised intracranial pressure increases CSF drainage through arachnoid villi and extracranial lymphatics. Am. J. Physiol. 275, R889–R896 (1998).

    CAS  PubMed  Google Scholar 

  142. Johnston, M., Armstrong, D. & Koh, L. Possible role of the cavernous sinus veins in cerebrospinal fluid absorption. Cerebrospinal Fluid Res. 4, 3 (2007).

    Article  PubMed  PubMed Central  Google Scholar 

  143. Malm, J., Kristensen, B., Markgren, P. & Ekstedt, J. CSF hydrodynamics in idiopathic intracranial hypertension: a long-term study. Neurology 42, 851–858 (1992).

    Article  CAS  PubMed  Google Scholar 

  144. Janny, P., Chazal, J., Colnet, G., Irthum, B. & Georget, A. M. Benign intracranial hypertension and disorders of CSF absorption. Surg. Neurol. 15, 168–174 (1981).

    Article  CAS  PubMed  Google Scholar 

  145. Alperin, N. et al. Evidence for altered spinal canal compliance and cerebral venous drainage in untreated idiopathic intracranial hypertension. Acta Neurochir. Suppl. 114, 201–205 (2012).

    Article  PubMed  Google Scholar 

  146. De Simone, R., Ranieri, A. & Bonavita, V. Advancement in idiopathic intracranial hypertension pathogenesis: focus on sinus venous stenosis. Neurol. Sci. 31 (Suppl. 1), S33–S39 (2010).

    Article  PubMed  Google Scholar 

  147. Higgins, J. N. & Pickard, J. D. Lateral sinus stenoses in idiopathic intracranial hypertension resolving after CSF diversion. Neurology 62, 1907–1908 (2004).

    Article  PubMed  Google Scholar 

  148. Lee, S. W., Gates, P., Morris, P., Whan, A. & Riddington, L. Idiopathic intracranial hypertension; immediate resolution of venous sinus “obstruction” after reducing cerebrospinal fluid pressure to <10 cmH2O. J. Clin. Neurosci. 16, 1690–1692 (2009).

    Article  PubMed  Google Scholar 

  149. Pickard, J. D., Czosnyka, Z., Czosnyka, M., Owler, B. & Higgins, J. N. Coupling of sagittal sinus pressure and cerebrospinal fluid pressure in idiopathic intracranial hypertension—a preliminary report. Acta Neurochir. Suppl. 102, 283–285 (2008).

    Article  CAS  PubMed  Google Scholar 

  150. Bono, F. et al. Transverse sinus stenoses persist after normalization of the CSF pressure in IIH. Neurology 65, 1090–1093 (2005).

    Article  CAS  PubMed  Google Scholar 

  151. Alper, F. et al. Importance of anatomical asymmetries of transverse sinuses: an MR venographic study. Cerebrovasc. Dis. 18, 236–239 (2004).

    Article  PubMed  Google Scholar 

  152. Kelly. L. et al. Does bilateral transverse cerebral venous sinus stenosis (TSS) really exist in patients without increased intracranial pressure (ICP)? Neurology 78 (Suppl. 1), P07.263 (2012).

    Google Scholar 

  153. Riggeal, B. et al. Does the presence of transverse sinus stenosis (TSS) influence the clinical presentation and outcome of idiopathic intracranial hypertension (IIH). Neurology 78 (Suppl. 1), P07.266 (2012).

    Google Scholar 

Download references

Acknowledgements

The authors' research work is supported by grants awarded to S.-J. Wang from the Taiwan National Science Council (100-2314-B-010-019-MY2, 100-2314-B-010-018-MY3) and Taipei Veterans General Hospital (VGHUST101-G7-1-1, V101C-106, V101E7-003). The authors also acknowledge National Science Council support for the Center for Dynamic Biomarkers and Translational Medicine, National Central University, Taiwan (NSC 100-2911-I-008-001), Brain Research Center, National Yang-Ming University and a grant from the Ministry of Education, Aim for the Top University Plan.

Author information

Authors and Affiliations

Authors

Contributions

K.-P. Peng researched the data for the article. K.-P. Peng, J.-L. Fuh and S.-J. Wang contributed equally to discussions of the content. K.-P. Peng wrote the article, and K.-P. Peng, J.-L. Fuh and S.-J. Wang reviewed and/or edited the manuscript before submission.

Corresponding author

Correspondence to Shuu-Jiun Wang.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Peng, KP., Fuh, JL. & Wang, SJ. High-pressure headaches: idiopathic intracranial hypertension and its mimics. Nat Rev Neurol 8, 700–710 (2012). https://doi.org/10.1038/nrneurol.2012.223

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneurol.2012.223

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing